{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:49:54Z","timestamp":1788191394933,"version":"build-2803163510"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["151508\/2022\u20134"],"award-info":[{"award-number":["151508\/2022\u20134"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["404610\/2021\u20138"],"award-info":[{"award-number":["404610\/2021\u20138"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["06\/09\/2023"],"award-info":[{"award-number":["06\/09\/2023"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.gene.2024.148252","type":"journal-article","created":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T17:37:08Z","timestamp":1707673028000},"page":"148252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management"],"prefix":"10.1016","volume":"907","author":[{"given":"Isabely Mayara da","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Geovana Leite","family":"Vacario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e1dia Calvo Martins","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Rafael Mazzaron","family":"Barcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Em\u00edlio","family":"Fuganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Losi","family":"Guembarovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilce Mara de Syllos","family":"C\u00f3lus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Mara","family":"Serpeloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2024.148252_b0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrurol.2018.5","article-title":"Bladder biomechanics and the use of scaffolds for regenerative medicine in the urinary bladder","volume":"15","author":"Ajalloueian","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.gene.2024.148252_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6244-6","article-title":"The prognostic impact of GSTM1\/GSTP1 genetic variants in bladder Cancer","volume":"19","author":"Albarakati","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gene.2024.148252_b0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10689-017-9991-z","article-title":"Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population","volume":"16","author":"Ali","year":"2017","journal-title":"Familial Cancer"},{"key":"10.1016\/j.gene.2024.148252_b0020","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41416-019-0722-0","article-title":"Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression","volume":"122","author":"Allain","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gene.2024.148252_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug Metabolism in the Liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gene.2024.148252_b0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5152\/tud.2018.23571","article-title":"Detection of CYP1A1 and GSTP1 gene polymorphisms in bladder cancer patients in a Turkish population using a polymerase chain reaction-restriction fragment length polymorphism method","volume":"44","author":"Altunkol","year":"2018","journal-title":"Turkish Journal of Urology"},{"key":"10.1016\/j.gene.2024.148252_b0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/bju.12641","article-title":"Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study","volume":"115","author":"Andrew","year":"2015","journal-title":"BJU International"},{"key":"10.1016\/j.gene.2024.148252_b0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/EDBK_175558","article-title":"New Developments and Challenges in Rare Genitourinary Tumors: Non-Urothelial Bladder Cancers and Squamous Cell Cancers of the Penis","volume":"37","author":"Aragon-Ching","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.gene.2024.148252_b0045","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.31557\/APJCP.2021.22.8.2479","article-title":"Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study","volume":"22","author":"Avirmed","year":"2021","journal-title":"Asian Pacific Journal of Cancer Prevention : APJCP"},{"key":"10.1016\/j.gene.2024.148252_b0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/mc.22784","article-title":"Differentiation-associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic-metabolizing activity of \u201cluminal\u201d muscle-invasive bladder cancers","volume":"57","author":"Baker","year":"2018","journal-title":"Molecular Carcinogenesis"},{"key":"10.1016\/j.gene.2024.148252_b0055","first-page":"207","article-title":"CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population","volume":"4","author":"Basma","year":"2013","journal-title":"International Journal of Molecular Epidemiology and Genetics"},{"key":"10.1016\/j.gene.2024.148252_b0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-069X-11-43","article-title":"Genetic variation in Glutathione S-Transferase Omega-1, Arsenic Methyltransferase and Methylene-tetrahydrofolate Reductase, arsenic exposure and bladder cancer: a case\u2013control study","volume":"11","author":"Beebe-Dimmer","year":"2012","journal-title":"Environmental Health"},{"key":"10.1016\/j.gene.2024.148252_b0065","doi-asserted-by":"crossref","unstructured":"Belkadi, A., Bolze, A., Itan, Y., Cobat, A., Vincent, Q.B., Antipenko, A., Shang, L., Boisson, B., Casanova, J.-L., Abel, L., 2015. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proceedings of the National Academy of Sciences 112, 5473\u20135478. Doi: 10.1073\/pnas.1418631112.","DOI":"10.1073\/pnas.1418631112"},{"key":"10.1016\/j.gene.2024.148252_b0070","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.7314\/APJCP.2013.14.6.3925","article-title":"CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population","volume":"14","author":"Berber","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.gene.2024.148252_b0075","series-title":"Goodman & Gilman\u2019s: the Pharmacological Basis of Therapeutics, 12e","article-title":"Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism, and Elimination","author":"Buxton","year":"2015"},{"key":"10.1016\/j.gene.2024.148252_b0080","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1289\/ehp.1002206","article-title":"Polymorphisms in GSTT1, GSTZ1, and CYP2E1, Disinfection By-products, and Risk of Bladder Cancer in Spain","volume":"118","author":"Cantor","year":"2010","journal-title":"Environmental Health Perspectives"},{"key":"10.1016\/j.gene.2024.148252_b0085","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11845-014-1200-6","article-title":"The effect of Glutathione-S-transferases in the susceptibility to bladder cancer","volume":"184","author":"Ceylan","year":"2015","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.gene.2024.148252_b0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"10.1016\/j.gene.2024.148252_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2018.06.028","article-title":"The multifaceted role of glutathione S-transferases in cancer","volume":"433","author":"Chatterjee","year":"2018","journal-title":"Cancer Lett"},{"issue":"Suppl 4","key":"10.1016\/j.gene.2024.148252_b0100","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.gene.2024.148252_b0105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eururo.2017.03.010","article-title":"Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset","volume":"72","author":"Choi","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.gene.2024.148252_b0110","first-page":"e2022017","article-title":"Mortality from bladder cancer in dyestuff workers exposed to aromatic amines: A 73-year follow-up","volume":"113","author":"Ciocan","year":"2022","journal-title":"Med Lav"},{"key":"10.1016\/j.gene.2024.148252_b0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12199-012-0302-x","article-title":"Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population","volume":"18","author":"Cui","year":"2013","journal-title":"Environmental Health and Preventive Medicine"},{"key":"10.1016\/j.gene.2024.148252_b0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ebiom.2016.08.036","article-title":"Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use","volume":"12","author":"Dadhania","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.gene.2024.148252_b0125","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1021\/acs.jcim.9b00836","article-title":"The Metabolic Rainbow: Deep Learning Phase I Metabolism in Five Colors","volume":"60","author":"Dang","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.gene.2024.148252_b0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/BLC-170159","article-title":"Bladder Cancer Genetic Susceptibility","volume":"4","author":"de Maturana","year":"2018","journal-title":"A Systematic Review. Bladder Cancer"},{"key":"10.1016\/j.gene.2024.148252_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/srep14000","article-title":"GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy","volume":"5","author":"Deng","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.gene.2024.148252_b0140","doi-asserted-by":"crossref","first-page":"110635","DOI":"10.18632\/oncotarget.22372","article-title":"Single nucleotide polymorphisms and cancer susceptibility","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2024.148252_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074724","article-title":"Glutathione S-Transferase T1, O1 and O2 Polymorphisms Are Associated with Survival in Muscle Invasive Bladder Cancer Patients","volume":"8","author":"Djukic","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gene.2024.148252_b0150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11255-015-0933-0","article-title":"GSTO1*C\/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder","volume":"47","author":"Djukic","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.gene.2024.148252_b0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/10937404.2017.1304736","article-title":"Polymorphisms of xenobiotic metabolizing enzymes in bladder cancer patients of the Semmelweis University Budapest, Hungary","volume":"80","author":"Ebbinghaus","year":"2017","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.gene.2024.148252_b0160","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/JU.0000000000000025","article-title":"Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016","volume":"201","author":"Ebrahimi","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.gene.2024.148252_b0165","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/mc.23232","article-title":"Slow N-acetylation as a possible contributor to bladder carcinogenesis","volume":"59","author":"El Kawak","year":"2020","journal-title":"Molecular Carcinogenesis"},{"key":"10.1016\/j.gene.2024.148252_b0170","doi-asserted-by":"crossref","first-page":"1474560","DOI":"10.1155\/2017\/1474560","article-title":"Combined Genetic Biomarkers Confer Susceptibility to Risk of Urothelial Bladder Carcinoma in a Saudi Population","volume":"2017","author":"Elhawary","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.gene.2024.148252_b0175","doi-asserted-by":"crossref","first-page":"22476","DOI":"10.1007\/s11356-017-9767-x","article-title":"Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population","volume":"24","author":"Feki-Tounsi","year":"2017","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.gene.2024.148252_b0180","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/carcin\/bgn163","article-title":"Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes","volume":"29","author":"Figueroa","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.gene.2024.148252_b0185","unstructured":"Flaig, T.W., Spiess, P.E., Abern, M., Agarwal, N., Bangs, R., Buyyounouski, M.K., Chan, K., Chang, S., Friedlander, T., Greenberg, R.E., Guru, K.A., Herr, H.W., Hoffman-Censits, J., 2023. Guidelines for Patients Details [WWW Document]. NCCN. URL https:\/\/www.nccn.org\/patientresources\/patient-resources\/guidelines-for-patients\/guidelines-for-patients-details (accessed 9.23.23)."},{"key":"10.1016\/j.gene.2024.148252_b0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00204-022-03380-5","article-title":"An integrative approach for identification of smoking-related genes involving bladder cancer","volume":"97","author":"Gao","year":"2023","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.gene.2024.148252_b0195","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1158\/1055-9965.EPI-10-1306","article-title":"GSTM1, GSTT1 Null Variants and GPX1 Single Nucleotide Polymorphism Are Not Associated With Bladder Cancer Risk in Egypt","volume":"20","author":"Goerlitz","year":"2011","journal-title":"Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"key":"10.1016\/j.gene.2024.148252_b0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1155\/2010\/816149","article-title":"GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer","volume":"29","author":"Ha","year":"2010","journal-title":"Disease Markers"},{"key":"10.1016\/j.gene.2024.148252_b0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3346\/jkms.2011.26.2.231","article-title":"GSTM1 Tissue Genotype as a Recurrence Predictor in Non-muscle Invasive Bladder Cancer","volume":"26","author":"Ha","year":"2011","journal-title":"Journal of Korean Medical Science"},{"key":"10.1016\/j.gene.2024.148252_b0210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13104-018-3132-0","article-title":"A synergic effect between CYP2C19*2, CYP2C19*3 loss-of-function and CYP2C19*17 gain-of-function alleles is associated with Clopidogrel resistance among Moroccan Acute Coronary Syndromes patients","volume":"11","author":"Hassani Idrissi","year":"2018","journal-title":"BMC Research Notes"},{"key":"10.1016\/j.gene.2024.148252_b0215","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s11033-021-06951-4","article-title":"Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort","volume":"49","author":"Hemissi","year":"2022","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.gene.2024.148252_b0220","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.urolonc.2010.08.028","article-title":"Polymorphisms of glutathione S-transferase \u03bc and \u03b8, MDR1 and VEGF genes as risk factors of bladder cancer: A case-control study","volume":"30","author":"Henr\u00edquez-Hern\u00e1ndez","year":"2012","journal-title":"Urologic Oncology: Seminars and Original Investigations, Obesity, Inactivity, Diabetes and Urologic Cancers"},{"key":"10.1016\/j.gene.2024.148252_b0225","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10937404.2017.1304727","article-title":"N-acetyltransferase 1*10 genotype in bladder cancer patients","volume":"80","author":"H\u00f6hne","year":"2017","journal-title":"Journal of Toxicology and Environmental Health, Part A"},{"key":"10.1016\/j.gene.2024.148252_b0230","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/ajco.12291","article-title":"N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population","volume":"11","author":"Hosen","year":"2015","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.gene.2024.148252_b0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.gene.2024.148252_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103349","article-title":"Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolism","volume":"27","author":"Isvoran","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.gene.2024.148252_b0245","series-title":"International Review of Cytology","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0074-7696(06)60002-8","article-title":"Molecular Mechanism of Phase I and Phase II Drug-Metabolizing Enzymes: Implications for Detoxification","author":"Iyanagi","year":"2007"},{"key":"10.1016\/j.gene.2024.148252_b0250","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/03602532.2013.835613","article-title":"Interactions of cytosolic sulfotransferases with xenobiotics","volume":"45","author":"James","year":"2013","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.gene.2024.148252_b0255","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5507\/bp.2010.017","article-title":"Phase II drug metabolizing enzymes","volume":"154","author":"Jancova","year":"2010","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.gene.2024.148252_b0260","series-title":"Frontiers in Plant Science 12","article-title":"Modified \u201cAllele-Specific qPCR\u201d Method for SNP Genotyping Based on FRET","author":"Kalendar","year":"2022"},{"key":"10.1016\/j.gene.2024.148252_b0265","doi-asserted-by":"crossref","unstructured":"Kang, H. won, Song, P.H., Ha, Y.-S., Kim, W.T., Kim, Y.-J., Yun, S.-J., Lee, S.-C., Choi, Y.H., Moon, S.-K., Kim, W.-J., 2013. Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility and outcomes in muscle invasive bladder cancer patients. Europ. J. Cancer 49, 3010\u20133019. Doi: 10.1016\/j.ejca.2013.05.019.","DOI":"10.1016\/j.ejca.2013.05.019"},{"key":"10.1016\/j.gene.2024.148252_b0270","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.urolonc.2013.10.013","article-title":"The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer","volume":"32","author":"Kang","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.gene.2024.148252_b0275","unstructured":"Kaseb, H., Aeddula, N.R., 2022. Bladder Cancer, in: StatPearls. StatPearls Publishing, Treasure Island (FL)."},{"key":"10.1016\/j.gene.2024.148252_b0280","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s12094-020-02325-7","article-title":"Drug-metabolizing enzymes: role in drug resistance in cancer","volume":"22","author":"Kaur","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.gene.2024.148252_b0285","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1245\/s10434-015-4431-5","article-title":"Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette-Guerin Instillation for Non-muscle Invasive Bladder Cancer","volume":"22","author":"Ke","year":"2015","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/j.gene.2024.148252_b0290","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00432-009-0758-2","article-title":"The impact of smoking and polymorphic enzymes of xenobiotic metabolism on the stage of bladder tumors: a generalized ordered logistic regression analysis","volume":"136","author":"Khedhiri","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.gene.2024.148252_b0295","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11033-010-0228-6","article-title":"Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population","volume":"38","author":"Klim\u010d\u00e1kov\u00e1","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.gene.2024.148252_b0300","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.7314\/APJCP.2013.14.5.3205","article-title":"Urinary Bladder Cancer Risk Factors: A Lebanese Case-Control Study","volume":"14","author":"Kobeissi","year":"2013","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"10.1016\/j.gene.2024.148252_b0305","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12920-022-01372-z","article-title":"Genetic susceptibility of bladder cancer in the Lebanese population","volume":"15","author":"Kourie","year":"2022","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.gene.2024.148252_b0310","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/ijc.26245","article-title":"Hair Dye Use and Risk of Bladder Cancer in the New England Bladder Cancer Study","volume":"129","author":"Koutros","year":"2011","journal-title":"International Journal of Cancer. Journal International Du Cancer"},{"key":"10.1016\/j.gene.2024.148252_b0315","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/ije\/dyv195","article-title":"Occupational exposure to pesticides and bladder cancer risk","volume":"45","author":"Koutros","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.gene.2024.148252_b0320","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.eururo.2023.04.020","article-title":"Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights","volume":"84","author":"Koutros","year":"2023","journal-title":"European Urology"},{"key":"10.1016\/j.gene.2024.148252_b0325","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/10937404.2017.1304719","article-title":"Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany","volume":"80","author":"Krech","year":"2017","journal-title":"Journal of Toxicology and Environmental Health, Part A"},{"key":"10.1016\/j.gene.2024.148252_b0330","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1248\/bpb.b16-00422","article-title":"CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers","volume":"39","author":"Kumondai","year":"2016","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/j.gene.2024.148252_b0335","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1248\/bpb.b15-00604","article-title":"Genetic Polymorphisms of CYP2A6 in a Case-Control Study on Bladder Cancer in Japanese Smokers","volume":"39","author":"Kumondai","year":"2016","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/j.gene.2024.148252_b0340","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/1940-6207.CAPR-15-0069","article-title":"Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction","volume":"9","author":"Lacombe","year":"2016","journal-title":"Cancer Prev Res (phila)"},{"key":"10.1016\/j.gene.2024.148252_b0345","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/BLC-211658","article-title":"Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors","volume":"8","author":"Lam","year":"2022","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.gene.2024.148252_b0350","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00008571-199410000-00002","article-title":"Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans","volume":"4","author":"Landi","year":"1994","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.gene.2024.148252_b0355","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.gene.2024.148252_b0360","article-title":"Influence of single nucleotide polymorphisms among cigarette smoking and non-smoking patients with coronary artery disease, urinary bladder cancer and lung cancer","volume":"16","author":"Lewin","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gene.2024.148252_b0365","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/ijc.27437","article-title":"Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk","volume":"131","author":"Lin","year":"2012","journal-title":"International Journal of Cancer. Journal International Du Cancer"},{"key":"10.1016\/j.gene.2024.148252_b0370","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10937404.2017.1304731","article-title":"Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis","volume":"80","author":"Lukas","year":"2017","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.gene.2024.148252_b0375","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.2741\/e517","article-title":"N-Acetyltransferase 2 genotype, exfoliated urothelial cells and benzidine exposure","volume":"4","author":"Ma","year":"2012","journal-title":"Front Biosci (elite Ed)"},{"key":"10.1016\/j.gene.2024.148252_b0380","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Medicine"},{"key":"10.1016\/j.gene.2024.148252_b0385","doi-asserted-by":"crossref","first-page":"e73587","DOI":"10.1371\/journal.pone.0073587","article-title":"In Silico Mechanistic Profiling to Probe Small Molecule Binding to Sulfotransferases","volume":"8","author":"Martiny","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.gene.2024.148252_b0390","article-title":"Does Occupational Exposure to Solvents and Pesticides in Association with Glutathione S-Transferase A1, M1, P1, and T1 Polymorphisms Increase the Risk of Bladder Cancer?","volume":"9","author":"Matic","year":"2014","journal-title":"The Belgrade Case-Control Study. Plos ONE"},{"key":"10.1016\/j.gene.2024.148252_b0395","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.urolonc.2011.08.005","article-title":"GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: A case-control study","volume":"31","author":"Matic","year":"2013","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"key":"10.1016\/j.gene.2024.148252_b0400","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1620\/tjem.240.25","article-title":"Common Polymorphisms in GSTA1, GSTM1 and GSTT1 Are Associated with Susceptibility to Urinary Bladder Cancer in Individuals from Balkan Endemic Nephropathy Areas of Serbia","volume":"240","author":"Matic","year":"2016","journal-title":"The Tohoku Journal of Experimental Medicine"},{"key":"10.1016\/j.gene.2024.148252_b0405","first-page":"45","volume":"80","author":"Matsuda","year":"2017","journal-title":"PCR-Based Detection Methods for Single-Nucleotide Polymorphism or Mutation"},{"key":"10.1016\/j.gene.2024.148252_b0410","doi-asserted-by":"crossref","first-page":"34625","DOI":"10.1038\/srep34625","article-title":"Aldo-keto reductase 1C1 induced by interleukin-1\u03b2 mediates the invasive potential and drug resistance of metastatic bladder cancer cells","volume":"6","author":"Matsumoto","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.gene.2024.148252_b0415","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00439-015-1631-9","article-title":"Clinical sequencing: is WGS the better WES?","volume":"135","author":"Meienberg","year":"2016","journal-title":"Hum Genet"},{"key":"10.1016\/j.gene.2024.148252_b0420","doi-asserted-by":"crossref","first-page":"25769","DOI":"10.1074\/jbc.M113.487785","article-title":"A Role for Glutathione Transferase Omega 1 (GSTO1-1) in the Glutathionylation Cycle","volume":"288","author":"Menon","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gene.2024.148252_b0425","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/00498254.2019.1618511","article-title":"N-acetyltransferase: the practical consequences of polymorphic activity in man","volume":"50","author":"Mitchell","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1016\/j.gene.2024.148252_b0430","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/carcin\/bgq223","article-title":"GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis","volume":"32","author":"Moore","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.gene.2024.148252_b0435","doi-asserted-by":"crossref","first-page":"14847","DOI":"10.1002\/jcb.28746","article-title":"Organochlorine and organophosphorus pesticides and bladder cancer: A case-control study","volume":"120","author":"Mortazavi","year":"2019","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.gene.2024.148252_b0440","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijscr.2020.09.068","article-title":"Inguinal lymph node metastasis of bladder carcinoma after radical cystectomy: A case report and review of literature","volume":"75","author":"Moussa","year":"2020","journal-title":"International Journal of Surgery Case Reports"},{"key":"10.1016\/j.gene.2024.148252_b0445","doi-asserted-by":"crossref","first-page":"733.e17","DOI":"10.1016\/j.urolonc.2021.05.034","article-title":"The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Gu\u00e9rin therapy for non-muscle invasive bladder cancer in a genome-wide association study","volume":"39","author":"Nagakawa","year":"2021","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"key":"10.1016\/j.gene.2024.148252_b0450","first-page":"2561","article-title":"Distribution and Role of N-acetyltransferase 2 Genetic Polymorphisms in Bladder Cancer Risk in a Lebanese Population","volume":"18","author":"Nasr","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.gene.2024.148252_b0455","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00253-017-8621-x","article-title":"Whole-cell-dependent biosynthesis of sulfo-conjugate using human sulfotransferase expressing budding yeast","volume":"102","author":"Nishikawa","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.gene.2024.148252_b0460","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/03602530701690366","article-title":"Drug-metabolizing enzymes in the skin of man, rat, and pig","volume":"39","author":"Oesch","year":"2007","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.gene.2024.148252_b0465","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.3390\/ijerph18084343","article-title":"Cancer Incidence and Mortality among Petroleum Industry Workers and Residents Living in Oil Producing Communities: A Systematic Review and Meta-Analysis","volume":"18","author":"Onyije","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.gene.2024.148252_b0470","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/15287394.2012.675308","article-title":"Polymorphic Enzymes, Urinary Bladder Cancer Risk, and Structural Change in the Local Industry","volume":"75","author":"Ovsiannikov","year":"2012","journal-title":"Journal of Toxicology and Environmental Health, Part A"},{"key":"10.1016\/j.gene.2024.148252_b0475","first-page":"663","article-title":"The Effect of CYP1A1 and GSTM1 Gene Polymorphisms in Bladder Cancer Development in a Turkish Population","volume":"25","author":"\u00d6zt\u00fcrk","year":"2011","journal-title":"In Vivo"},{"key":"10.1016\/j.gene.2024.148252_b0480","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.7314\/APJCP.2013.14.11.6375","article-title":"GSTP1 Gene Ile105Val Polymorphism Causes an Elevated Risk for Bladder Carcinogenesis in Smokers","volume":"14","author":"Pandith","year":"2013","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"10.1016\/j.gene.2024.148252_b0485","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biopha.2018.05.117","article-title":"Drug metabolizing enzymes and their inhibitors\u2019 role in cancer resistance","volume":"105","author":"Pathania","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.gene.2024.148252_b0490","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10654-010-9479-8","article-title":"CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer","volume":"25","author":"Pavanello","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.gene.2024.148252_b0495","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/13543776.2017.1379503","article-title":"Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review","volume":"27","author":"Penning","year":"2017","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/j.gene.2024.148252_b0500","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1158\/1055-9965.EPI-13-0119-T","article-title":"N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort","volume":"22","author":"Pesch","year":"2013","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.gene.2024.148252_b0505","doi-asserted-by":"crossref","unstructured":"Pi\u00f1eros, M., Laversanne, M., Barrios, E., Cancela, M. de C., Vries, E. de, Pardo, C., Bray, F., 2022. An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean. The Lancet Regional Health \u2013 Americas 13. Doi: 10.1016\/j.lana.2022.100294.","DOI":"10.1016\/j.lana.2022.100294"},{"key":"10.1016\/j.gene.2024.148252_b0510","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/02841860902913546","article-title":"Occupation and cancer - follow-up of 15 million people in five Nordic countries","volume":"48","author":"Pukkala","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.gene.2024.148252_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2022.110402","article-title":"Identification of a metabolism-related gene signature predicting overall survival for bladder cancer","volume":"114","author":"Qiu","year":"2022","journal-title":"Genomics"},{"key":"10.1016\/j.gene.2024.148252_b0520","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.989030","article-title":"The impact of genetic variants in the CYP2C8 gene on bladder cancer susceptibility","volume":"13","author":"Qu","year":"2022","journal-title":"Front Endocrinol (lausanne)"},{"key":"10.1016\/j.gene.2024.148252_b0525","doi-asserted-by":"crossref","first-page":"40012","DOI":"10.18632\/oncotarget.9475","article-title":"Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population","volume":"7","author":"Quan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2024.148252_b0530","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: an update","volume":"38","author":"Richters","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.gene.2024.148252_b0535","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/JU.0000000000000593","article-title":"Use and Validation of the AUA\/SUO Risk Grouping for Nonmuscle Invasive Bladder Cancer in a Contemporary Cohort","volume":"203","author":"Ritch","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.gene.2024.148252_b0540","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s12253-011-9398-3","article-title":"Smoking and Polymorphisms in Xenobiotic Metabolism and DNA Repair Genes are Additive Risk Factors Affecting Bladder Cancer in Northern Tunisia","volume":"17","author":"Rouissi","year":"2011","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.gene.2024.148252_b0545","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2148-13-62","article-title":"Rapid birth-and-death evolution of the xenobiotic metabolizing NAT gene family in vertebrates with evidence of adaptive selection","volume":"13","author":"Sabbagh","year":"2013","journal-title":"BMC Evolutionary Biology"},{"key":"10.1016\/j.gene.2024.148252_b0550","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urolonc.2011.11.027","article-title":"Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility","volume":"31","author":"Safarinejad","year":"2013","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"key":"10.1016\/j.gene.2024.148252_b0555","first-page":"15","article-title":"Epidemiology of Bladder Cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Med Sci (basel)"},{"key":"10.1016\/j.gene.2024.148252_b0560","doi-asserted-by":"crossref","unstructured":"Salinas, -S\u00e1nchez Antonio S., Donate, -Moreno Mar\u00eda J., L, \u00f3pez-G.M.-P., Gim, \u00e9nez-B.J.M., Escribano, J., 2012. Role of CYP1B1 Gene Polymorphisms in Bladder Cancer Susceptibility. J. Urol. 187, 700\u2013706. Doi: 10.1016\/j.juro.2011.10.063.","DOI":"10.1016\/j.juro.2011.10.063"},{"key":"10.1016\/j.gene.2024.148252_b0565","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/j.1464-410X.2010.09683.x","article-title":"Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer","volume":"107","author":"Salinas-S\u00e1nchez","year":"2011","journal-title":"BJU International"},{"key":"10.1016\/j.gene.2024.148252_b0570","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.tig.2020.07.006","article-title":"Alternative Applications of Genotyping Array Data Using Multi-Variant Methods","volume":"36","author":"Samuels","year":"2020","journal-title":"Trends Genet"},{"key":"10.1016\/j.gene.2024.148252_b0575","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.urolonc.2015.11.010","article-title":"CYP1B1 gene polymorphisms correlate with an increased risk of urinary bladder cancer in India","volume":"34","author":"Sankhwar","year":"2016","journal-title":"Urologic Oncology: Seminars and Original Investigations, Seminar on Immunotherapy and Cancer Vaccines"},{"key":"10.1016\/j.gene.2024.148252_b0580","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"Sanli","year":"2017","journal-title":"Bladder Cancer. Nat Rev Dis Primers"},{"key":"10.1016\/j.gene.2024.148252_b0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/1351000212Y.0000000031","article-title":"GSTM1-null and GSTA1-low activity genotypes are associated with enhanced oxidative damage in bladder cancer","volume":"18","author":"Savic-Radojevic","year":"2013","journal-title":"Redox Report : Communications in Free Radical Research"},{"key":"10.1016\/j.gene.2024.148252_b0590","doi-asserted-by":"crossref","first-page":"e51880","DOI":"10.1371\/journal.pone.0051880","article-title":"Distinct SNP Combinations Confer Susceptibility to Urinary Bladder Cancer in Smokers and Non-Smokers","volume":"7","author":"Schwender","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.gene.2024.148252_b0595","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00204-013-1157-7","article-title":"Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk","volume":"87","author":"Selinski","year":"2013","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.gene.2024.148252_b0600","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.eururo.2016.12.007","article-title":"Ultra-slow N-Acetyltransferase 2 Is Associated with Recurrence-free Time in Bladder Cancer Patients","volume":"71","author":"Selinski","year":"2017","journal-title":"European Urology"},{"key":"10.1016\/j.gene.2024.148252_b0605","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/dmdi-2014-0028","article-title":"Pharmacogenetics of drug-metabolizing enzymes in Italian populations","volume":"30","author":"Serpe","year":"2015","journal-title":"Drug Metab Pers Ther"},{"key":"10.1016\/j.gene.2024.148252_b0610","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jbt.10071","article-title":"Changes in expression and activity of glutathione S-transferase in different organs of schistosoma haematobium-infected hamster","volume":"17","author":"Sheweita","year":"2003","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.gene.2024.148252_b0615","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.gene.2024.148252_b0620","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.gene.2024.148252_b0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144077","article-title":"Glutathione S-Transferase Pi 1 (GSTP1) Gene 313 A\/G (rs1695) polymorphism is associated with the risk of urinary bladder cancer: Evidence from a systematic review and meta-analysis based on 34 case-control studies","volume":"719","author":"Song","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.gene.2024.148252_b0630","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40262-021-01001-5","article-title":"Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes","volume":"60","author":"Song","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.gene.2024.148252_b0635","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15026298","article-title":"CYP1A2-163C\/A (rs762551) polymorphism and bladder cancer risk: a case-control study","volume":"15","author":"Song","year":"2016","journal-title":"Genetics and Molecular Research"},{"key":"10.1016\/j.gene.2024.148252_b0640","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00280-020-04181-2","article-title":"Involvement of cytochrome P450 enzymes in inflammation and cancer: a review","volume":"87","author":"Stipp","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.gene.2024.148252_b0645","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/carcin\/19.3.433","article-title":"Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1\u20131 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons","volume":"19","author":"Sundberg","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.gene.2024.148252_b0650","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.gene.2024.148252_b0655","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.gene.2024.148252_b0660","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1002\/cam4.4654","article-title":"The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness","volume":"11","author":"Teleka","year":"2022","journal-title":"Cancer Medicine"},{"key":"10.1016\/j.gene.2024.148252_b0665","first-page":"2615","article-title":"Association of AKR1C3 Polymorphisms with Bladder Cancer","volume":"13","author":"Tiryakioglu","year":"2016","journal-title":"Urol J"},{"key":"10.1016\/j.gene.2024.148252_b0675","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jfma.2012.08.015","article-title":"Combined effects of GSTO1 and SULT1A1 polymorphisms and cigarette smoking on urothelial carcinoma risk in a Taiwanese population","volume":"113","author":"Tung","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.gene.2024.148252_b0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43586-021-00056-9","article-title":"Genome-wide association studies","volume":"1","author":"Uffelmann","year":"2021","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/j.gene.2024.148252_b0685","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcp.2019.05.018","article-title":"Molecular and functional characterization of cytosolic sulfotransferases in cynomolgus macaque","volume":"166","author":"Uno","year":"2019","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.gene.2024.148252_b0690","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-3565(24)29543-4","article-title":"Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate","volume":"297","author":"Venkatakrishnan","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.gene.2024.148252_b0695","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/03602532.2019.1632886","article-title":"Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it","volume":"51","author":"Verma","year":"2019","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.gene.2024.148252_b0700","article-title":"Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing","volume":"13","author":"Wang","year":"2022","journal-title":"Frontiers in Genetics"},{"key":"10.1016\/j.gene.2024.148252_b0705","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.cell.2021.03.015","article-title":"Genotyping arrays are extremely unreliable for detecting very rare variants in human genetic studies: an example from a recent study of MC4R","volume":"184","author":"Weedon","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.gene.2024.148252_b0710","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.acuro.2012.04.007","article-title":"Estudio sobre susceptibilidad de c\u00e1ncer de vejiga y polimorfismos gen\u00e9ticos de XPC, XPG y CYP en fumadores y no fumadores","volume":"37","author":"Wen","year":"2013","journal-title":"Actas Urol\u00f3gicas Espa\u00f1olas"},{"key":"10.1016\/j.gene.2024.148252_b0670","unstructured":"Tissue expression of NAT2 - Summary - The Human Protein Atlas [WWW Document], 2024. URL https:\/\/www.proteinatlas.org\/ENSG00000156006-NAT2\/tissue (accessed 3.3.23)."},{"key":"10.1016\/j.gene.2024.148252_b0715","unstructured":"Wickham, H., Chang, W., Henry, L., Pedersen, T.L., Takahashi, K., Wilke, C., Woo, K., Yutani, H., Dunnington, D., Posit, PBC, 2023. ggplot2: Create Elegant Data Visualisations Using the Grammar of Graphics."},{"key":"10.1016\/j.gene.2024.148252_b0720","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.urolonc.2010.09.007","article-title":"Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt","volume":"30","author":"Wolpert","year":"2012","journal-title":"Urologic Oncology"},{"key":"10.1016\/j.gene.2024.148252_b0725","doi-asserted-by":"crossref","unstructured":"Wu, T., Hu, E., Xu, S., Chen, M., Guo, P., Dai, Z., Feng, T., Zhou, L., Tang, W., Zhan, L., Fu, X., Liu, S., Bo, X., Yu, G., 2021. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2. Doi: 10.1016\/j.xinn.2021.100141.","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"10.1016\/j.gene.2024.148252_b0730","doi-asserted-by":"crossref","first-page":"2988159","DOI":"10.1155\/2022\/2988159","article-title":"Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated with Bladder Cancer in the Northeast Chinese Population","volume":"2022","author":"Wu","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.gene.2024.148252_b0735","doi-asserted-by":"crossref","DOI":"10.1038\/srep11751","article-title":"Functional POR A503V is associated with the risk of bladder cancer in a Chinese population","volume":"5","author":"Xiao","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.gene.2024.148252_b0740","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1124\/dmd.120.000074","article-title":"The Role of Sulfotransferases in Liver Diseases","volume":"48","author":"Xie","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.gene.2024.148252_b0745","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/ijc.34228","article-title":"The causal association between smoking, alcohol consumption and risk of bladder cancer: A univariable and multivariable Mendelian randomization study","volume":"151","author":"Xiong","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gene.2024.148252_b0750","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.2147\/CMAR.S175062","article-title":"Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis","volume":"10","author":"Yan","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.gene.2024.148252_b0755","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.2147\/CMAR.S189220","article-title":"Mortality trends of bladder cancer in China from 1991 to 2015: an age-period-cohort analysis","volume":"11","author":"Yang","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.gene.2024.148252_b0760","doi-asserted-by":"crossref","first-page":"e0249632","DOI":"10.1371\/journal.pone.0249632","article-title":"Evaluation of association studies and a systematic review and meta-analysis of CYP1A1 T3801C and A2455G polymorphisms in breast cancer risk","volume":"16","author":"Yang","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.gene.2024.148252_b0765","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/tpj.2012.42","article-title":"Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications","volume":"13","author":"Yiannakopoulou","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.gene.2024.148252_b0770","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C5MB00663E","article-title":"ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization","volume":"12","author":"Yu","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.gene.2024.148252_b0775","first-page":"228","article-title":"Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer","volume":"3","author":"Zhang","year":"2012","journal-title":"International Journal of Molecular Epidemiology and Genetics"},{"key":"10.1016\/j.gene.2024.148252_b0780","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12885-019-5924-6","article-title":"Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gene.2024.148252_b0785","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/gtmb.2010.0162","article-title":"Genetic Polymorphisms of Glutathione S-Transferase P1 and Bladder Cancer Susceptibility in a Chinese Population","volume":"15","author":"Zhang","year":"2011","journal-title":"Genetic Testing and Molecular Biomarkers"},{"key":"10.1016\/j.gene.2024.148252_b0790","doi-asserted-by":"crossref","first-page":"12808","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 Enzymes and Drug Metabolism in Humans","volume":"22","author":"Zhao","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.gene.2024.148252_b0795","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/11318070-000000000-00000","article-title":"Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II","volume":"48","author":"Zhou","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.gene.2024.148252_b0800","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41397-022-00288-2","article-title":"The genetic landscape of major drug metabolizing cytochrome P450 genes\u2014an updated analysis of population-scale sequencing data","volume":"22","author":"Zhou","year":"2022","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.gene.2024.148252_b0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00122-013-2177-7","article-title":"Copy number polymorphism in plant genomes","volume":"127","author":"\u017bmie\u0144ko","year":"2014","journal-title":"TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111924001331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111924001331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T17:11:52Z","timestamp":1759857112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111924001331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":161,"alternative-id":["S0378111924001331"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2024.148252","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2024.148252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"148252"}}